HomeRRMS

  • FLX-787 in Multiple Sclerosis displays positive Phase 2 Topline results

    • March 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Successful results for Multiple Sclerosis MAb GNbAC1 announced by GeNeuro and Servier in Phase 2b CHANGE-MS Study

    • March 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • 1
  • 2